Steven Bernstein
Analyst · the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this conference call. It is now my pleasure to turn the floor over to your host, Thomas McClelland, President and Chief Executive Officer
Thank you, Tom, and good afternoon. Before I go through the financial results, it's important to mention that even though we are not presenting FY '23 Q2, the company has made significant improvements from FY '23 Q2 compared to FY '23 Q3. Sales increased $1.6 million or 18.6%. Gross margin went from 3.9% to 32.6%, and operating profit loss went from a loss of $2.28 million to income of $325,000. These are substantial improvements, and we continue to strive to make changes to keep this trend continuing. The 3 months ended January 31, '23 consolidated revenue was $10.6 million compared to $12.2 million for the same period of the prior fiscal year. The components of revenue are as follows: Revenue of commercial and U.S. government satellite programs was approximately $5 million or 47% compared to $7.5 million or 62% in the same period of the prior fiscal year. Revenue on satellite payload contracts are recognized primarily under the percentage of completion method and are recorded only in the FEI-New York segment. Revenues from non-space U.S. government and DOD customers, which are recorded in both the FEI-New York and FEI-Zyfer segments, were $5 million compared to $4.3 million in the same period of the prior fiscal year and accounted for approximately 47% of consolidated revenue compared to 35% for the prior fiscal year. Other commercial and industrial revenue were approximately $650,000 compared to approximately $400,000 in the prior fiscal year. The decrease in revenue for the 3 months ended January 31, '23 was mainly due to the timing of the various production phases for products in the satellite market. For the 3 months ended January 31, '23, gross margin and gross margin rate increased as compared to the same period in fiscal year '22. The increase in gross margin and gross margin rate was due to higher engineering costs associated with programs in the development phase in the prior-year period versus the production phase during the current-year period. For the 3 months ended January 31, '23 and '22, SG&A expenses were approximately 22% and 23%, respectively, of consolidated revenues. The decrease in SG&A expense for the 3 months ending January 31, '23 as compared to prior-year period was largely due to a decrease in payroll and associated costs related to the previously announced workforce reduction. The company continues to monitor expenses looking for additional cost-effective reductions, going forward. R&D expense for the 3 months ended January 31, '23, decreased to approximately $780,000 from $1.1 million for the 3 months ending January 31, '22, a decrease of approximately $345,000, and were approximately 7% and 9%, respectively, of consolidated revenue. R&D decreased for the 3 months ending January 31, '23 are related to resolution of fiscal year '22 technical challenges to projects that are now in production phase. The company plans to continue to invest in R&D in the future to keep its products at the state of the art. For the 3 months ending January 31, '23, the company recorded operating income of approximately $325,000 compared to an operating loss of approximately $720,000 in the prior year. Operating income increased due to a combination of increase in sales over the 3 months ending October 31, '22, increased gross margin and effects of the changes management has instituted. Other income consists primarily investment activity derived from the company's holdings of marketable securities. During the 3 months ending January 31, '23, the company liquidated its holdings and as a result, there was a loss recognized. This yields a pretax loss of approximately $313,000 compared to an approximately $734,000 pretax loss for the prior fiscal year. It is important to mention, as a result of the liquidation of the company's holdings and marketable securities and the associated loss, the pretax loss would have been pretax income. For the 3 months ending January 31, '23, the company recorded a tax provision of $3,000 compared to $1,000 for the same period of the prior fiscal year. Consolidated net loss for the 3 months ending January 31, '23, was approximately $316,000 or $0.03 per share compared to an approximately $735,000 net loss or $0.08 per share in the previous fiscal year. Our fully-funded backlog at the end of January '23, was approximately $54 million compared to $40 million for the previous fiscal year ending April 30, '22. In addition, this is the second consecutive quarter in which backlog is greater than [$15 million], levels the company hasn't seen in years. While some of this will turn into revenue and thus come out of backlog this year, we expect additional significant contract awards to be added to backlog in the coming quarters. The company's balance sheet continues to reflect the strong working capital position of approximately $20 million at January 31, '23 and a current ratio of approximately 1.7:1. Additionally, the company's debt-free. The company believes that its liquidity is adequate to meet its operating investing needs for the next 12 months and the foreseeable future. I will turn the call back to Tom, and we look forward to your questions.